Evidence map›Paper›PMID 36891478›Full record

ArticleeNeurologicalSci2023

HTLV-1-associated demyelinating neuropathy: A case report and review of the literature.

Keiko Tamaki, Takayasu Mishima, Yuji Tateishi, Hidekazu Mera, Hiromu Ogura, Jun Tsugawa, Shinsuke Fujioka, Yasushi Takamatsu, Yoshio Tsuboi

Abstract readCase Reports
PubMed Full text at PMC Publisher
In one paragraph

Article in eNeurologicalSci, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Keiko TamakiDepartment of Neurology, Fukuoka University, Japan.
Takayasu MishimaDepartment of Neurology, Fukuoka University, Japan.
Yuji TateishiDepartment of Neurology, Fukuoka University, Japan.
Hidekazu MeraDepartment of Neurology, Fukuoka University, Japan.
Hiromu OguraDepartment of Neurology, Fukuoka University, Japan.
Jun TsugawaDepartment of Neurology, Fukuoka University, Japan.
Shinsuke FujiokaDepartment of Neurology, Fukuoka University, Japan.
Yasushi TakamatsuDivision of Medical Oncology, Hematology and Infectious Diseases, Fukuoka University, Japan.
Yoshio TsuboiDepartment of Neurology, Fukuoka University, Japan.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

A 78-year-old man developed paresthesias in the extremities. He was referred to our hospital because of positive anti-human T-cell leukemia virus type 1 (HTLV-1) antibodies in the serum and the presence of abnormal lymphocytes. He was diagnosed as chronic-type adult T-cell leukemia/lymphoma. Neurological examination revealed sensory impairment in the distal parts of the extremities with loss of deep tendon reflexes. Nerve conduction study showed motor and sensory demyelinating polyneuropathy, indicating a diagnosis of HTLV-1-associated demyelinating neuropathy. Corticosteroid therapy followed by intravenous immunoglobulin therapy improved his symptoms. Since demyelinating neuropathy associated with HTLV-1 infection is not well recognized, we here report its characteristics and clinical course through our case report and literature review.

Indexed as

Adult T-cell leukemia/lymphomaATL, adult T-cell leukemia/lymphomaCIDP, chronic inflammatory demyelinating polyneuropathyCorticosteroidCSF, cerebrospinal fluidCXCL10, C-X-C motif chemokine 10HAM/TSP, HTLV-1-associated myelopathy/tropical spastic paraparesisHTLV-1HTLV-1-associated demyelinating neuropathyHTLV-1, human T-cell leukemia virus type 1Intravenous immunoglobulin therapyIVIg, intravenous immunoglobulinmPSL, methylprednisolone

Identifiers

PMID36891478
PMCPMC9986509

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.